Picture of CoDon AG logo

CNW CoDon AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+1.27%
3m-30.55%
6m-41.54%
1yr-59.53%
Volume Change (%)
10d/3m-22.48%
Price vs... (%)
52w High-76.15%
50d MA-17.06%
200d MA-39.77%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-105.88%
Return on Equity-134.62%
Operating Margin-133.86%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of CoDon AG EPS forecast chart

Profile Summary

Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
September 14th, 1999
Public Since
February 1st, 2001
No. of Employees
134
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
de flag iconFrankfurt Stock Exchange
Shares in Issue
26,723,248.91
Blurred out image of a map
Address
Warthestrasse 21, TELTOW, 14513
Web
https://www.codon.de/
Phone
+49 332843460
Contact
Matthias Meissner
Auditors
Mazars GmbH Wirtschaftsprufungsgesellschaft

CNW Share Price Performance

Upcoming Events for CNW

Similar to CNW

Picture of Apontis Pharma AG logo

Apontis Pharma AG

de flag iconFrankfurt Stock Exchange

Picture of Bayer AG logo

Bayer AG

de flag iconFrankfurt Stock Exchange

FAQ